{"abstract": "The Carlyle Group is in exclusive talks to buy Johnson & Johnson\u2019s blood-testing unit, in what could lead to a transaction worth about $4 billion, a person briefed on the matter said on Monday.", "web_url": "https://dealbook.nytimes.com/2013/12/23/carlyle-said-in-talks-for-johnson-johnson-unit/", "snippet": "The Carlyle Group is in exclusive talks to buy Johnson & Johnson\u2019s blood-testing unit, in what could lead to a transaction worth about $4 billion, a person briefed on the matter said on Monday.", "lead_paragraph": "The Carlyle Group is in exclusive talks to buy Johnson & Johnson\u2018s blood-testing unit, in what could lead to a transaction worth about $4 billion, a person briefed on the matter said on Monday.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Carlyle Said in Talks for Johnson & Johnson Unit", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "subject", "value": "Tests (Medical)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Carlyle Group LP", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 4, "major": "N"}], "pub_date": "2013-12-24T01:43:37+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/870a9d45-de3c-59ec-96d9-50dcf78ac542", "word_count": 193, "uri": "nyt://article/870a9d45-de3c-59ec-96d9-50dcf78ac542"}